A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

TY - JOUR

T1 - A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

AU - Gatzemeier, U

AU - Faderl, B

AU - Macha, H

AU - Kaukel, E

AU - Deppermann, K.-M

AU - Bonnet, Reiner B.

AU - Hessler, S

PY - 2000/9/1

Y1 - 2000/9/1

UR - http://linkinghub.elsevier.com/retrieve/pii/S0169500200800902

U2 - 10.1016/S0169-5002(00)80090-2

DO - 10.1016/S0169-5002(00)80090-2

M3 - Article

VL - 29

JO - Lung Cancer

JF - Lung Cancer

ER -